| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2004-11-4394 |
| P698 | PubMed publication ID | 15746080 |
| P2093 | author name string | Anna Laurell | |
| Göran Roos | |||
| Christer Sundström | |||
| Richard Rosenquist | |||
| Magnus Hultdin | |||
| Anna Aleskog | |||
| Karin Karlsson | |||
| Ulf Thunberg | |||
| Gerard Tobin | |||
| Pawel Grabowski | |||
| P2860 | cites work | Extension of life-span by introduction of telomerase into normal human cells | Q24336088 |
| P433 | issue | 12 | |
| P921 | main subject | chronic lymphocytic leukemia | Q1088156 |
| P304 | page(s) | 4807-4812 | |
| P577 | publication date | 2005-03-03 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status | |
| P478 | volume | 105 |
| Q92066176 | 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia |
| Q38835730 | Association between telomere length and survival in cancer patients: a meta-analysis and review of literature |
| Q58245553 | Association of shorter mean telomere length with large artery stiffness in patients with coronary heart disease |
| Q36384860 | CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells |
| Q34568204 | Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q37603583 | Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones |
| Q36372866 | Empirical evaluation of humpback whale telomere length estimates; quality control and factors causing variability in the singleplex and multiplex qPCR methods |
| Q28394031 | Epidemiologic evidence for a role of telomere dysfunction in cancer etiology |
| Q36322450 | Impact of telomere length on survival in classic and variant hairy cell leukemia |
| Q37588785 | Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance |
| Q33964355 | Leukocyte telomere length and plasma catestatin and myeloid-related protein 8/14 concentrations in children with obstructive sleep apnea |
| Q35635651 | Long telomeres are associated with clonality in wild populations of the fissiparous starfish Coscinasterias tenuispina |
| Q35140580 | Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia |
| Q34045020 | Reliability and short-term intra-individual variability of telomere length measurement using monochrome multiplexing quantitative PCR. |
| Q37140625 | Search for a correlation between telomere length and severity of retinitis pigmentosa due to the dominant rhodopsin Pro23His mutation |
| Q92615045 | Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia |
| Q35501952 | Shorter telomeres associate with a reduced risk of melanoma development |
| Q39712077 | Shorter telomeres in patients with cerebral autosomal dominant arteriopathy and leukoencephalopathy (CADASIL). |
| Q34102906 | Shorter telomeres in peripheral blood mononuclear cells from older persons with sarcopenia: results from an exploratory study |
| Q37127542 | Tailoring of chronic lymphatic leukemia therapy |
| Q58276318 | Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome |
| Q33334405 | Telomere attrition due to infection |
| Q85040909 | Telomere disrupts, CLL progresses |
| Q34132146 | Telomere length and heredity: Indications of paternal inheritance |
| Q35643026 | Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes |
| Q79777424 | Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients |
| Q34973576 | Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. |
| Q30986040 | Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial. |
| Q52941092 | Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia. |
| Q60345319 | Telomeres and prognosis in patients with chronic lymphocytic leukaemia |
| Q48311718 | Telomeres and telomerase as novel drug targets: reflections on the 2009 Nobel Prize in Physiology or Medicine |
| Q37705182 | Telomeres and telomerase in normal and malignant B-cells. |
| Q47430351 | The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab |
| Q55377785 | The expression of telomere-related proteins and DNA damage response and their association with telomere length in colorectal cancer in Saudi patients. |
| Q36849336 | The role of prognostic factors in assessing 'high-risk' subgroups of patients with chronic lymphocytic leukemia |
| Q37782260 | The use of telomere length in ecology and evolutionary biology. |
Search more.